InvestorsHub Logo
Followers 0
Posts 23
Boards Moderated 0
Alias Born 01/10/2010

Re: None

Tuesday, 03/16/2010 12:39:33 PM

Tuesday, March 16, 2010 12:39:33 PM

Post# of 60
Last chance to buy under 2$ ...

Urocidin (Bladder cancer) PIII results in April 2010 .Urocidin has BLOCKBUSTER POTENTIAL !!!!


Bioniche Life Science (BNC.TO)

Market Cap: 105 Mio C$
Cash: 30 Mio C$
Price: 1,21 C$


Upcoming Milestones

2009/2010 Conditional license for E. coli cattle vaccine in the U.S.

2009/2010 Achievement of pre-commercialization milestone payments for
UrocidinTM

2010 First U.S. sales of E. coli cattle vaccine

2010 Results of refractory Phase III bladder cancer trial

2011 Belleville, ON vaccine manufacturing centre operational



Insider activity
http://canadianinsider.com/coReport/allTransactions.php?ticker=bnc




Strong Bullish Chart
http://www.barchart.com/opinions/BNC.TO



Urocidin Potential New Treatment for Bladder Cancer
http://www.associatedcontent.com/article/1939454/urocidin_potential_new_treatment_for_pg3.html?cat=70


Urocidin (Bladder Cancer) PII Results
http://www.medicalnewstoday.com/articles/139517.php



Discussion board of people dealing with bladder cancer and discussing BCG treatment and MCC
http://www.inspire.com/groups/bladder-cancer-advocacy-network/discussion/bcg-protocol/?page=1#replies





Crystal Research 18.02.2010
http://www.crystalra.com/pdf/BNC_2QFY10_Update_02-18-10.pdf